Liraglutide in Spinal Fluid

NCT02104037 · Completed

Last updated 2026-05-28

This clinical trial tests whether the diabetes medication liraglutide can enter the spinal fluid in adults with diabetes or obesity.

Status Completed The study has finished.

Phase Not applicable Not a phased drug trial (e.g. a device or behavioral study).

Type Interventional (clinical trial)

Design Non-randomized, open-label (no blinding) basic-science study

Participants 8 people

Who can join Ages 18+ · all sexes

Timeline Started 2012-01

Where 1 site · Denmark

What this study is testing ClinicalTrials.gov NCT02104037 ↗

Description as written by the study sponsor.

The purpose of this study is to investigate transfer of liraglutide from blood to cerebrospinal fluid.

Main thing measured	cerebrospinal fluid concentration of liraglutide
Sponsor	Mikkel Christensen
Conditions studied	Liraglutide Blood-brain Transfer
GLP-1 drugs	liraglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT02104037 ↗